Phibro Animal Health PAHC Payments Of Debt Issuance Costs

Payments Of Debt Issuance Costs at other companies

NeogenNEOG

——

Other financials

Income statement

See full

Revenue$383.5M+10.3%

Gross profit$125.7M+20.2%

Operating income$44.7M+33.2%

Net income$24.0M+15.1%

EPS (diluted)$0.59+15.7%

Balance sheet

See full

Cash & equivalents$54.9M-9.0%

Total debt$32.3M+27.8%

Total equity$361.8M+36.0%

Total assets$1.4B+9.7%

Cash flow

See full

Operating cash flow$16.2M-62.4%

CapEx$15.3M+97.7%

Free cash flow$890.0K-97.5%

Valuation

See full

Market cap$1.27B+31.4%

Enterprise value$1.25B+33.9%

P/E13.4×-17.1×

P/S0.9×0.0×

Profitability

See full

Gross margin32.5%+0.9pp

Operating margin12%+4.0pp

Net margin6.3%+3.7pp

FCF margin0.9%-3.3pp

Returns & leverage

See full

Return on equity30.3%+18.5pp

Debt / equity0.1×0.0×

Current ratio3.2×+0.3×

Where this comes from

Reported directly by Phibro Animal Health in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfDebtIssuanceCosts.

The official record: Phibro Animal Health’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about Phibro Animal Health's payments of debt issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Phibro Animal Health's payments of debt issuance costs?: Phibro Animal Health (PAHC) reported payments of debt issuance costs of $10.38M in Q3 2024.